CClinicalTrials.gg
CompletedNCT07426497COCCY-OMT-GIBUpdated Jul 24, 2026

Osteopathic Manual Therapy vs Ganglion Impar Block for Chronic Coccydynia: A Randomized Controlled Trial

An interventional study of Osteopathic Manual Therapy and Ganglion Impar Block in Coccydynia, Chronic Pain and Coccygodynia, sponsored by Istanbul Medeniyet University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-07-24.

Sponsored by Istanbul Medeniyet University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 5 months after the study started (first participant enrolled Aug 2025, registered Feb 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
105
Allocation
Randomized
Ages
18 Years to 75 Years
Sex
All
01

Study summary

Chronic coccydynia is a condition characterized by persistent pain in the coccyx region that can significantly impair sitting tolerance, daily activities, and quality of life. Various conservative and interventional treatment options have been described, including manual therapy techniques and ganglion impar block. However, the comparative effectiveness of these approaches remains unclear.

The aim of this randomized controlled study is to compare the effects of osteopathic manual therapy and ganglion impar block on pain intensity and functional disability in patients with chronic coccydynia. Participants will be randomly assigned to one of the two treatment groups. Pain severity will be assessed using the Numeric Rating Scale (NRS), and functional status will be evaluated with the Oswestry Disability Index (ODI) at baseline, week 3, and month 3.

The results of this study are expected to provide evidence regarding the relative effectiveness of these two commonly used treatment methods and to guide clinicians in selecting appropriate management strategies for patients with chronic coccydynia.

Read the detailed description

Chronic coccydynia is a multifactorial pain syndrome affecting the coccygeal region and is often associated with trauma, prolonged sitting, obesity, or idiopathic causes. Patients frequently report severe localized pain that worsens with sitting and transitions from sitting to standing. Conservative treatment options include physical therapy modalities and manual therapy techniques, while interventional procedures such as ganglion impar block are commonly used in refractory cases.

This prospective randomized controlled trial aims to compare the clinical effectiveness of osteopathic manual therapy and ganglion impar block in patients with chronic coccydynia. Eligible patients will be randomly allocated into two groups. The osteopathic manual therapy group will receive standardized manual therapy sessions targeting pelvic alignment, sacrococcygeal mobility, and surrounding soft tissue structures. The ganglion impar block group will undergo fluoroscopy-guided ganglion impar injection performed under sterile conditions.

The outcome measures will include pain intensity assessed by the Numeric Rating Scale (NRS) and functional disability assessed by the Oswestry Disability Index (ODI). Assessments will be performed at baseline, week 3, and month 3 follow-up.

The study is conducted at Medicana Zincirlikuyu Hospital in collaboration with Istanbul Atlas University. Ethical approval has been obtained from the Istanbul Atlas University Clinical Research Ethics Committee. The findings of this trial will contribute to the evidence base regarding non-surgical management options for chronic coccydynia.

02

Conditions studied

  • Coccydynia
  • Chronic Pain
  • Coccygodynia

Browse trials for

Keywords

  • Chronic coccydynia
  • Ganglion impar block
  • Osteopathic manual therapy
  • Coccyx pain
  • Manual therapy
  • Interventional pain
  • Numeric Rating Scale
03

In context

Chronic Pain

2,930 studies on the registry are indexed under Chronic Pain; 699 are open to participants now.

This study's enrollment of 105 is above the median of 60 across 2,160 interventional studies indexed under Chronic Pain.

Browse Chronic Pain studies →

Lead sponsor

Istanbul Medeniyet University is the lead sponsor of 188 studies on the registry; 18 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age 18-75 years
  • Chronic coccygodynia ≥3 months
  • Baseline NRS ≥4
  • ODI ≥20
  • Failure of prior conservative treatment
  • Imaging excludes fracture, infection, or malignancy
  • Ability to provide written informed consent

Exclusion criteria

Exclusion Criteria:

  • Acute coccygodynia
  • Prior spinal or coccygeal surgery
  • Malignancy
  • Pelvic fracture
  • Pregnancy
  • Coagulation disorder
  • Severe psychiatric disease
  • Prior osteopathic manual therapy or ganglion impar block
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
105 participants (actual)

Study arms

  • Experimental
    Osteopathic Manual Therapy

    Participants received osteopathic manual therapy targeting the coccygeal and sacrococcygeal region. Techniques included myofascial release, ligamentous tension balancing, and gentle mobilization. Treatment was applied once weekly for 3 weeks.

    Procedure: Osteopathic Manual Therapy

  • Experimental
    Ganglion Impar Block

    Participants received a single ganglion impar block performed under fluoroscopic guidance using local anesthetic with corticosteroid. No additional manual therapy was applied.

    Procedure: Ganglion Impar Block

Interventions

  • ProcedureOsteopathic Manual Therapy

    Osteopathic manual therapy was applied to the sacrococcygeal region. Techniques included myofascial release, ligamentous tension balancing, and gentle mobilization. Treatment was performed once weekly for three consecutive weeks by a certified practitioner.

  • ProcedureGanglion Impar Block

    A single ganglion impar block was performed under fluoroscopic guidance using local anesthetic combined with corticosteroid. The procedure was carried out under sterile conditions without additional manual therapy.

06

What researchers measure

Primary outcomes

  1. Oswestry Disability Index (ODI) change from baseline

    Change in functional disability measured by the Oswestry Disability Index (ODI, 0-100; 0 = no disability, 100 = maximum disability; higher scores indicate worse disability). Mean change from baseline to 3 months will be compared between groups.

    Time frame: Baseline and 3 months

  2. Patient Global Impression of Change (PGIC) score

    Patient Global Impression of Change (PGIC; 7-point scale from 1 = very much improved to 7 = very much worse; lower scores indicate better outcome). Mean PGIC score will be compared between groups.

    Time frame: 3 weeks and 3 months

  3. Oswestry Disability Index (ODI) change at 3 weeks

    Change in functional disability measured by the Oswestry Disability Index (ODI, 0-100; higher scores indicate worse disability). Mean change from baseline to 3 weeks will be compared between groups.

    Time frame: Baseline and 3 weeks

  4. Numeric Rating Scale (NRS) pain change at 3 weeks

    Change in pain intensity measured by the Numeric Rating Scale (NRS, 0-10; 0 = no pain, 10 = worst imaginable pain; higher scores indicate worse pain). Mean change from baseline to 3 weeks will be compared between groups.

    Time frame: Baseline and 3 weeks

  5. Numeric Rating Scale (NRS) pain change at 3 months

    Change in pain intensity measured by the Numeric Rating Scale (NRS, 0-10; higher scores indicate worse pain). Mean change from baseline to 3 months will be compared between groups.

    Time frame: Baseline and 3 months

07

Study locations

1 site
  • Medicana Zincirlikuyu Hospital
    Istanbul, Sisli 34394, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 24, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07426497
Lead sponsor
Istanbul Medeniyet University
Responsible party
Bilinç Doğruöz Karatekin (Associate professor, Istanbul Medeniyet University) — Principal investigator
First posted
Feb 23, 2026
Start date
Aug 28, 2025
Primary completion
Feb 16, 2026
Completion
Feb 16, 2026
Last update
Jul 24, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion